Clinical Outcomes of Selenium Supplementation in Hashimoto's Thyroiditis Without Selenium Deficiency: A Large‐Scale Retrospective Cohort Study
Open Access
- 18 May 2026
- journal article
- research article
- Published by Wiley in Endocrinology, Diabetes & Metabolism
- Vol. 9 (3) , e70239
Abstract
Introduction: Selenium supplementation has been suggested as a therapeutic option for Hashimoto's thyroiditis, but its effects on thyroid function and other patient‐related outcomes remain unclear. Methods: This retrospective cohort study utilised a global federated health research network to compare patients with Hashimoto's thyroiditis who received selenium supplementation after diagnosis to those who did not. Propensity score matching was performed to balance baseline characteristics. Primary outcomes included longitudinal thyroid function measures, while secondary outcomes included development of autoimmune diseases, thyroid cancer, need for thyroidectomy and all‐cause mortality. All outcomes were followed for 5 years. Results: After matching, 2347 patients were included in each cohort. Selenium supplementation was associated with persistently higher mean TSH, free T4 and TPOAb levels, as well as greater proportions of elevated TPOAb (> 35 IU/mL) at 3 years (6.9% vs. 5.0%, p = 0.01) and 5 years (7.9% vs. 5.3%, p < 0.01). The incidence of autoimmune disorders was higher in the selenium group (RR 1.33, 95% CI 1.14–1.56), particularly Sjögren's syndrome (RR 1.61, 95% CI 1.03–2.52) and psoriasis (RR 2.69, 95% CI 1.52–4.76). The rates of thyroid cancer and need for thyroidectomy were similar between groups. However, selenium use was associated with increased all‐cause mortality (RR 1.38, 95% CI 1.09–2.03). Conclusion: Selenium supplementation in Hashimoto's thyroiditis was associated with worsened biochemical autoimmunity, increased autoimmune comorbidity and higher mortality. These findings should be interpreted cautiously given the absence of baseline selenium measurements, which limits assessment of deficiency status. Nevertheless, they highlight the need for further research to confirm these results.Keywords
This publication has 37 references indexed in Scilit:
- The Combined Effects of an Anti‐Inflammatory Diet and Curcumin Supplementation on Thyroid Function and Lipid Profile in Patients With Hashimoto's Thyroiditis: A Double Blind Randomised Clinical TrialEndocrinology, Diabetes & Metabolism, 2025
- Selenium regulates T cell differentiation in experimental autoimmune thyroiditis in miceInternational Immunopharmacology, 2023
- Selenium, selenoproteins and cancer of the thyroidJournal of Trace Elements in Medicine and Biology, 2022
- Hashimotos’ thyroiditis: Epidemiology, pathogenesis, clinic and therapyBest Practice & Research Clinical Endocrinology & Metabolism, 2019
- Vitiligo and Hashimoto’s thyroiditis: Autoimmune diseases linked by clinical presentation, biochemical commonality, and autoimmune/oxidative stress-mediated toxicity pathogenesisMedical Hypotheses, 2019
- Global epidemiology of hyperthyroidism and hypothyroidismNature Reviews Endocrinology, 2018
- Selenium supplementation for Hashimoto's thyroiditisCochrane Database of Systematic Reviews, 2013
- Selenium Supplementation in the Treatment of Hashimoto's Thyroiditis: A Systematic Review and a Meta-analysisThyroid®, 2010
- Prevalence and Relative Risk of Other Autoimmune Diseases in Subjects with Autoimmune Thyroid DiseaseThe American Journal of Medicine, 2010
- Selenium in food and the human body: A reviewScience of The Total Environment, 2008